直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Conference

LSX World Congress USA

September 16-17, 2025

Boston, MA

Informa Connect

Finnegan is a Silver Sponsor of the Informa Connect LSX World Congress USA. Finnegan partner Ryan O’Quinn will moderate the panel discussion "Licensing Goldmines: Turning Intellectual Property into Biotech Success." The conference will take place at The Boston Convention and Exhibition Center in Boston, Massachusetts. For more information, or to register, please visit the event website.

Related Practices

Diligence, Licensing, and Opinions

Licensing, Pooling, and Other Transactions

Related Industries

Life Sciences

Biotechnology

Related Offices

Reston, VA

Related Professionals

Ryan P. O'Quinn, Ph.D.
Partner
Reston, VA
+1 571 203 2426
Email

Related Insights

Articles

Enforcing Your Patent Rights at Sea: A UK Perspective

June 18, 2026

Articles

The SECURE Data Act: A Federal Privacy Framework Moves Forward

June 16, 2026

Articles

The TAKE IT DOWN Act Is Now in Full Effect: What Platforms Need to Know

June 16, 2026

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Lecture

Latest Developments in U.S. Section 337 Investigations and Response Strategies

June 12, 2026

Dongguan

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments – June 2026

June 8, 2026

Articles

The Breakaway Problem: What USA Masters Weightlifting Got Wrong and What Every Splinter Group Should Know

May 29, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP